General discussion, page-1612

Another excellent reason to stay out of the OTC market in the future and focus on IP/prescription based product where you would imagine the margins are sufficient to maintain a higher standard of quality. Let others trash their branding for the sake of a few rubles.

I'd also like to see an investigation into the use of synthetics. From the little I have gleaned (mainly from BOT) if you have to scale up production, it maybe more time and cost effective to rely on a synthetic product produced on a lab assembly line rather then a natural product which is at the mercy of mother nature and an immature supply chain.

I'm still researching this, if anyone else has an opinion on the subject, I'd love to hear your thoughts.

+1 for the oil sale update